Value of different noninvasive diagnostic models in the diagnosis of esophageal and gastric varices with significant portal hypertension in compensated hepatitis B cirrhosis

Cheng LIU; Jiayi ZENG; Mengbing FANG; Zhiheng CHEN; Bei GUI; Fengming ZHAO; Jingkai YUAN; Chaozhen ZHANG; Meijie SHI; Yubao XIE; Xiaoling CHI; Huanming XIAO

doi:10.12449/JCH250211

Volume 41 Issue 2

Feb. 2025

Turn off MathJax

Article Contents

Article Navigation > Journal of Clinical Hepatology > 2025 > 41(2): 263-268

PDF( 919 KB)

Value of different noninvasive diagnostic models in the diagnosis of esophageal and gastric varices with significant portal hypertension in compensated hepatitis B cirrhosis

DOI: 10.12449/JCH250211

1.
The Second Clinical Medical College of Guangzhou University of Chinese Medicine，Guangzhou 510006，China
2.
The Liver Department，Guangdong Provincial Hospital of Traditional Chinese Medicine，The Second Affiliated Hospital of Guangzhou University of Chinese Medicine，Guangzhou 510006，China

Research funding:

The Thirteenth Five-Year Plan for Major and Special Programs of the National Science and Technologyof China (2018ZX10725506-003);

The Thirteenth Five-Year Plan for Major and Special Programs of the National Science and Technologyof China (2018ZX10725505-004);

Guangdong Provincial Key Laboratory of Chinese Medicine for Prevention and Treatment of Refractory Chronic Diseases (the Second Hospital of Chinese Medicine［2023］200);

Guangdong Provincial Natural Science Foundation (2022A1515220188);

Guangdong Provincial Natural Science Foundation (2023A1515011092);

Guangdong Provincial Natural Science Foundation (2022A1515110825);

The Clinical Research Projects of Guangdong Provincial Hospital of Chinese Medicine (YN10101903);

The Clinical Research Projects of Guangdong Provincial Hospital of Chinese Medicine (YN2016XP03);

The Clinical Research Projects of Guangdong Provincial Hospital of Chinese Medicine (YN2022DB04);

The Clinical Research Projects of Guangdong Provincial Hospital of Chinese Medicine (YN2023MB04);

Chi Xiaoling of Project of Inheritance Workshop of Famous Old Chinese Medicine Experts of State Administration of Traditional Chinese Medicine (Guozhong Pharmaceutical Human Education Letter ［2022］ No.75);

The Fifth Batch of National Research and Training Programs for Clinical Talents of Traditional Chinese Medicine (Guozhong Pharmaceutical Human Education Letter ［2022］ No.1)

More Information

Corresponding author: XIAO Huanming， xiaohuanming@163.com （ORCID： 0000-0002-8739-0720）
Received Date: 2024-06-29
Accepted Date: 2024-07-22
Published Date: 2025-02-25

Abstract

Abstract

Objective To investigate the value of different noninvasive diagnostic models in the diagnosis of esophageal and gastric varices since there is a high risk of esophageal and gastric varices in patients with compensated hepatitis B cirrhosis and significant portal hypertension， and to provide a basis for the early diagnosis of esophageal and gastric varices. Methods A total of 108 patients with significant portal hypertension due to compensated hepatitis B cirrhosis who attended Guangdong Provincial Hospital of Traditional Chinese Medicine from November 2017 to November 2023 were enrolled， and according to the presence or absence of esophageal and gastric varices under gastroscopy， they were divided into esophageal and gastric varices group （GOV group） and non-esophageal and gastric varices group （NGOV group）. Related data were collected， including age， sex， imaging findings， and laboratory markers. The chi-square test was used for comparison of categorical data between groups； the least significant difference t-test was used for comparison of normally distributed continuous data between groups， and the Mann-Whitney U test was used for comparison of non-normally distributed continuous data between groups. The receiver operating characteristic （ROC） curve was plotted to evaluate the diagnostic value of five scoring models， i.e.， fibrosis-4 （FIB-4）， LOK index， LPRI， aspartate aminotransferase-to-platelet ratio index （APRI）， and aspartate aminotransferase/alanine aminotransferase ratio （AAR）. The binary logistic regression method was used to establish a combined model， and the area under the ROC curve （AUC） was compared between the combined model and each scoring model used alone. The Delong test was used to compare the AUC value between any two noninvasive diagnostic models. Results There were 55 patients in the GOV group and 53 patients in the NGOV group. Compared with the NGOV group， the GOV group had a significantly higher age （52.64±1.44 years vs 47.96±1.68 years， t=0.453， P<0.05） and significantly lower levels of alanine aminotransferase ［42.00 （24.00 — 17.00） U/L vs 82.00 （46.00 — 271.00） U/L， Z=-3.065， P<0.05］， aspartate aminotransferase ［44.00 （32.00 — 96.00） U/L vs 62.00 （42.50 — 154.50） U/L，Z=-2.351， P<0.05］， and platelet count ［100.00 （69.00 — 120.00）×10⁹/L vs 119.00 （108.50 — 140.50）×10⁹/L， Z=-3.667， P<0.05］. The ROC curve analysis showed that FIB-4， LOK index， LPRI， and AAR used alone had an accuracy of 0.667， 0.681， 0.730， and 0.639， respectively， in the diagnosis of esophageal and gastric varices （all P<0.05）， and the positive diagnostic rates of GOV were 69.97%， 65.28%， 67.33%， and 58.86%， respectively， with no significant differences in AUC values （all P>0.05）， while APRI used alone had no diagnostic value （P>0.05）. A combined model （LAF） was established based on the binary logistic regression analysis and had an AUC of 0.805 and a positive diagnostic rate of GOV of 75.80%， with a significantly higher AUC than FIB-4， LOK index， LPRI， and AAR used alone （Z=-2.773，-2.479，-2.206， and-2.672， all P<0.05）. Conclusion FIB-4， LOK index， LPRI， and AAR have a similar diagnostic value for esophageal and gastric varices in patients with compensated hepatitis B cirrhosis and significant portal hypertension， and APRI alone has no diagnostic value. The combined model LAF had the best diagnostic efficacy， which provides a certain reference for clinical promotion and application.
- Liver Cirrhosis,
- Hepatitis B,
- Hypertension， Portal,
- Esophageal and Gastric Varices

FullText(HTML)

References(24)

References

[1]	MORRISON JD, MENDOZA-ELIAS N, LIPNIK AJ, et al. Gastric varices bleed at lower portosystemic pressure gradients than esophageal varices[J]. J Vasc Interv Radiol, 2018, 29( 5): 636- 641. DOI: 10.1016/j.jvir.2017.10.014.
[2]	Chinese Society of Hepatology, Chinese Society of Gastroenterology, and Chinese Society of Digestive Endoscopology of Chinese Medical Association. Guidelines on the management of esophagogastric variceal bleeding in cirrhotic portal hypertension[J]. J Clin Hepatol, 2023, 39( 3): 527- 538. 中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会消化内镜学分会. 肝硬化门静脉高压食管胃静脉曲张出血的防治指南[J]. 临床肝胆病杂志, 2023, 39( 3): 527- 538.
[3]	de FRANCHIS R, BOSCH J, GARCIA-TSAO G, et al. Baveno VII-Renewing consensus in portal hypertension[J]. J Hepatol, 2022, 76( 4): 959- 974. DOI: 10.1016/j.jhep.2021.12.022.
[4]	DENG H, QI X, PENG Y, et al. Diagnostic accuracy of APRI, AAR, FIB-4, FI, and King Scores for diagnosis of esophageal varices in liver cirrhosis: A retrospective study[J]. Med Sci Monit, 2015, 21: 3961- 3977. DOI: 10.12659/msm.895005.
[5]	YAN YJ, LI Y, FAN CL, et al. A novel machine learning-based radiomic model for diagnosing high bleeding risk esophageal varices in cirrhotic patients[J]. Hepatol Int, 2022, 16( 2): 423- 432. DOI: 10.1007/s12072-021-10292-6.
[6]	GINES P, KRAG A, ABRAIDES JG, et al. Liver cirrhosis[J]. Lancet, 2021, 398( 10308): 1359- 1376. DOI: 10.1016/S0140-6736(21)01374-X
[7]	PARK JJ, PARK JY, KIM DY, et al. Prediction of significant fibrosis in chronic hepatitis C patients with normal ALT[J]. Hepatogastroenterology, 2011, 58( 109): 1321- 1327. DOI: 10.5754/hge11041.
[8]	Chinese Society of Hepatology, Chinese Medical Association; Chinese Society of Infectious Diseases, Chinese Medical Association. Guidelines for the prevention and treatment of chronic hepatitis B(version 2022)[J]. Chin J Infect Dis, 2023, 41( 1): 3- 28. DOI: 10.3760/cma.j.cn311365-20230220-00050. 中华医学会肝病学分会, 中华医学会感染病学分会. 慢性乙型肝炎防治指南(2022年版)[J]. 中华传染病杂志, 2023, 41( 1): 3- 28. DOI: 10.3760/cma.j.cn311365-20230220-00050.
[9]	Chinese Society of Hepatology, Chinese Medical Association. Chinese guidelines on the management of liver cirrhosis[J]. J Clin Hepatol, 2019, 35( 11): 2408- 2425. DOI: 10.3969/j.issn.1001-5256.2019.11.006. 中华医学会肝病学分会. 肝硬化诊治指南[J]. 临床肝胆病杂志, 2019, 35( 11): 2408- 2425. DOI: 10.3969/j.issn.1001-5256.2019.11.006.
[10]	SUN DY. Predictive value of FIB-4, Lok and King scores for esophageal varices in liver cirrhosis[D]. Hefei: Anhui Medical University, 2021. 孙迪一. FIB-4、Lok和King评分对肝硬化食管静脉曲张的预测价值[D]. 合肥: 安徽医科大学, 2021.
[11]	LI N, ZHENG SQ, ZHAO SS. Application of FibroS can, APRI, FIB-4 and GPR in prediction of esophageal varices in patients with liver cirrhosis[J]. J Pract Hepatol, 2020, 23( 4): 560- 563. DOI: 10.3969/j.issn.1672-5069.2020.04.027. 李娜, 郑少秋, 赵守松. FibroScan联合多种预测模型预测肝硬化患者食管静脉曲张程度应用价值探讨[J]. 实用肝脏病杂志, 2020, 23( 4): 560- 563. DOI: 10.3969/j.issn.1672-5069.2020.04.027.
[12]	ZHU X, XI XL, HAN JT. Predictive value of serum fibrosis index-4 APRI AAR for esophageal and gastric varices in patients with hepatitis B cirrhosis[J]. Med Forum, 2024, 28( 1): 22- 25. DOI: 10.19435/j.1672-1721.2024.01.007. 朱欣, 习晓丽, 韩江涛. 血清学指标纤维化指数-4 APRI AAR对乙型肝炎肝硬化患者食管胃底静脉曲张的预测价值[J]. 基层医学论坛, 2024, 28( 1): 22- 25. DOI: 10.19435/j.1672-1721.2024.01.007.
[13]	WANG SM, WANG N, YU Z, et al. Diagnostic values of APRI, AAR, and FIB-4 predictive models in autoimmune cirrhosis combined with esophagogastric fundal varices[J]. J Jilin Univ(Med Ed), 2024, 50( 2): 523- 528. DOI: 10.13481/j.1671-587X.20240227. 王素梅, 王楠, 于珍, 等. APRI、AAR和FIB-4等预测模型对自身免疫性肝硬化伴食管胃底静脉曲张的诊断价值[J]. 吉林大学学报(医学版), 2024, 50( 2): 523- 528. DOI: 10.13481/j.1671-587X.20240227.
[14]	CHEN ZM, HUANG DY, LIU HY, et al. Clinical value of transient elastography combined with aspartate aminotransferase to platelet ratio index and fibrosis index based on four factors for predicting the severity of esophageal varices in hepatic cirrhosis[J]. Acad J Guangzhou Med Univ, 2016, 44( 2): 22- 25. DOI: 10.3969/j.issn.1008-1836.2016.02.006. 陈志敏, 黄德扬, 刘惠媛, 等. 瞬时弹性成像联合天冬氨酸转氨酶/血小板比值指数和FIB-4指数预测肝硬化食管静脉曲张程度的临床价值[J]. 广州医科大学学报, 2016, 44( 2): 22- 25. DOI: 10.3969/j.issn.1008-1836.2016.02.006.
[15]	WAI CT, GREENSON JK, FONTANA RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C[J]. Hepatology, 2003, 38( 2): 518- 526. DOI: 10.1053/jhep.2003.50346.
[16]	GIANNINI E, RISSO D, BOTTA F, et al. Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease[J]. Arch Intern Med, 2003, 163( 2): 218- 224. DOI: 10.1001/archinte.163.2.218.
[17]	VALLET-PICHARD A, MALLET V, NALPAS B, et al. FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest[J]. Hepatology, 2007, 46( 1): 32- 36. DOI: 10.1002/hep.21669.
[18]	OHTA T, SAKAGUCHI K, FUJIWARA A, et al. Simple surrogate index of the fibrosis stage in chronic hepatitis C patients using platelet count and serum albumin level[J]. Acta Med Okayama, 2006, 60( 2): 77- 84. DOI: 10.18926/AMO/30729.
[19]	QI XS, LI HY, CHEN J, et al. Serum liver fibrosis markers for predicting the presence of gastroesophageal varices in liver cirrhosis: A retrospective cross-sectional study[J]. Gastroenterol Res Pract, 2015, 2015: 274534. DOI: 10.1155/2015/274534.
[20]	ZHOU JL, WANG BQ, SUN YM, et al. Application value of liver stiffness measurement-to-platelet ratio index score in diagnosis of hepatitis B liver fibrosis and liver cirrhosis[J]. J Clin Hepatol, 2022, 38( 7): 1529- 1533. DOI: 10.3969/j.issn.1001-5256.2022.07.014. 周家玲, 王冰琼, 孙亚朦, 等. LPRI评分在乙型肝炎肝纤维化及肝硬化中的诊断价值[J]. 临床肝胆病杂志, 2022, 38( 7): 1529- 1533. DOI: 10.3969/j.issn.1001-5256.2022.07.014.
[21]	SEBASTIANI G, TEMPESTA D, FATTOVICH G, et al. Prediction of oesophageal varices in hepatic cirrhosis by simple serum non-invasive markers: Results of a multicenter, large-scale study[J]. J Hepatol, 2010, 53( 4): 630- 638. DOI: 10.1016/j.jhep.2010.04.019.
[22]	TAFAREL JR, TOLENTINO LHL, CORREA LM, et al. Prediction of esophageal varices in hepatic cirrhosis by noninvasive markers[J]. Eur J Gastroenterol Hepatol, 2011, 23( 9): 754- 758. DOI: 10.1097/MEG.0b013e3283488a88.
[23]	DENG H, QI XS, GUO XZ. Diagnostic accuracy of APRI, AAR, FIB-4, FI, king, lok, forns, and FibroIndex scores in predicting the presence of esophageal varices in liver cirrhosis: A systematic review and meta-analysis[J]. Medicine(Baltimore), 2015, 94( 42): e1795. DOI: 10.1097/MD.0000000000001795.
[24]	BERZIGOTTI A, GILABERT R, ABRALDES JG, et al. Noninvasive prediction of clinically significant portal hypertension and esophageal varices in patients with compensated liver cirrhosis[J]. Am J Gastroenterol, 2008, 103( 5): 1159- 1167. DOI: 10.1111/j.1572-0241.2008.01826.x.

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(1) / Tables(2)

Get Citation

PDF

XML

Article Metrics

Article views (1978) PDF downloads(51)

Value of different noninvasive diagnostic models in the diagnosis of esophageal and gastric varices with significant portal hypertension in compensated hepatitis B cirrhosis

DOI: 10.12449/JCH250211

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content